查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1798028

2032 年抗衰老治療市場預測：按衰老類型、分子類型、作用機制、藥物類別、分銷管道、應用和地區進行的全球分析

Anti-aging Therapeutics Market Forecasts to 2032 - Global Analysis By Type of Aging, Type of Molecule, Mechanism of Action, Drug Class, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球抗衰老治療市場預計在 2025 年達到 9.9112 億美元，到 2032 年將達到 34.734 億美元，預測期內的複合年成長率為 19.62%。

抗衰老療法是指旨在預防、減緩或逆轉與老化相關的生物過程的療法、干預措施和產品。這些療法旨在透過針對導致老化的細胞損傷、氧化壓力、發炎和遺傳因素，延長健康壽命、改善外觀並維持生理功能。這些療法包括藥物、生技藥品、再生療法、荷爾蒙替代療法和營養補充劑。抗衰老療法還可以治療與年齡相關的疾病，例如心血管疾病、神經退化和骨質疏鬆症。

生物技術和基因組學的進展

精準醫療技術透過根據患者的基因組成客製化治療方法，提高了安全性和有效性。基因編輯、幹細胞療法和再生醫學的進展為修復細胞損傷和延緩老化提供了新的方法。基因組研究透過辨識生物標記和老化相關基因，加速了新藥的研發。這些進展減少了治療方法設計中的試驗，並加快了成功治療方法的上市速度。

缺乏長期臨床證據

由於長期療效未經證實，消費者對產品的有效性持續存疑。由於數據不足，產品難以獲得監管部門的核准。投資者可能不願意為缺乏強力臨床支持的項目提供資金。這導致新治療方法的研發和上市受到拖延。

提高消費者意識並專注於預防性護理

越來越多的人正在尋求保持健康和青春的方法。那些具有預防性健康觀念的人更有可能在註意到明顯的衰老跡象之前就開始治療。這種觀念的轉變推動了尖端抗衰老療法和解決方案的早期採用。市場擴張也得益於人們對活性成分和精良配方益處的日益認知。因此，各公司正集中行銷和研發力量，以服務於這群精明的客戶群。

治療費用高且報銷有限

相當一部分人口仍然無力承擔許多先進的治療。有限的保險覆蓋和報銷規定進一步加重了患者的經濟負擔，阻礙了他們接受美容和預防性護理。因此，高所得群體仍是最大的需求群體。這些經濟障礙阻礙了整體市場的擴張和可近性。

COVID-19的影響

新冠疫情爆發嚴重衝擊了抗衰老治療市場，擾亂了供應鏈，推遲了臨床試驗，並影響了生產業務。選擇性和非緊急治療的限制導致患者就診量減少，產品採用速度放緩。然而，這場危機也間接地支持了市場的長期成長，因為它提升了消費者對健康、保健和預防保健的興趣。向遠端醫療和數位平台的轉變使得人們能夠持續獲得諮詢和產品資訊。疫情後的復甦將受到對先進抗衰老解決方案需求的復甦、研發投入的增加以及美容和治療程序的恢復的推動。

預計細胞衰老領域將成為預測期內最大的細分市場

預計細胞老化領域將在預測期內佔據最大的市場佔有率，該領域針對的是細胞層面老化的根本原因，例如DNA損傷、端粒縮短和氧化壓力。抗衰老藥物、端粒酶活化劑和細胞再生療法的創新正在推動對先進解決方案的需求。針對細胞修復機制的研究投入和臨床試驗的增加，進一步推動了市場的成長。消費者對預防性醫療保健和長壽意識的不斷提高，推動了這些治療方法的採用。因此，細胞衰老領域對整個抗衰老治療市場的擴張做出了重大貢獻。

預計認知功能部分將在預測期內實現最高的複合年成長率

認知功能領域預計將在預測期內實現最高成長率，因為它致力於解決與老化相關的記憶力、注意力和思維敏銳度的下降。人們對阿茲海默症和失智症神經退化性疾病的認知不斷提高，推動了對預防和治療解決方案的需求。趨向性、神經保護藥物和再生療法的進展正在拓寬治療選擇。大腦健康補充劑和生活方式干涉措施的日益普及，進一步推動了市場成長。認知增強研究和臨床試驗的不斷增加，正在增強該領域對整個抗衰老市場的貢獻。

比最大的地區

預計北美地區將在預測期內佔據最大的市場佔有率，這得益於與生活方式相關的衰老疾病的高發性、強大的醫療基礎設施以及對先進再生藥物不斷成長的需求。幹細胞療法、基因編輯和胜肽療法等技術正日益受到重視。新興趨勢包括個人化抗衰老解決方案和人工智慧主導的早期療育診斷。關鍵進展包括生物技術公司與研究機構在新型藥物傳輸系統的合作。

複合年成長率最高的地區

預計亞太地區將在預測期內實現最高的複合年成長率，這得益於人口老化、可支配收入成長以及預防保健意識的增強。奈米醫學、草藥療法和微生物組調節等技術正在興起。趨勢包括傳統醫學與現代醫學的融合以及對非侵入性治療的需求。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場參與企業進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 透過產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 介紹
  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球抗老治療市場（依老化類型）

  • 介紹
  • 細胞老化
  • 免疫老化
  • 代謝性衰老
  • 其他類型的衰老

6. 全球抗衰老治療市場（按分子類型）

  • 介紹
  • 生技藥品
  • 小分子

7. 全球抗衰老治療市場（按作用機制）

  • 介紹
  • 老化抑制劑
  • 細胞再生
  • mTor調變器
  • AMPK活化劑
  • 端粒酶活化劑
  • 其他作用機制

8. 全球抗老治療市場（依藥物類別）

  • 介紹
  • 荷爾蒙療法
  • 抗氧化劑
  • 酵素
  • 幹細胞療法
  • 其他

9. 全球抗衰老治療市場（按分銷管道）

  • 介紹
  • 醫院藥房
  • 零售藥局
  • 線上平台

第 10 章全球抗衰老治療市場（按應用）

  • 介紹
  • 皮膚和頭髮健康
  • 骨骼和肌肉健康
  • 認知功能
  • 與年齡相關的疾病
  • 其他

第 11 章全球抗衰老治療市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章：企業概況

  • Unity BIoTechnology
  • Novartis AG
  • Roche Holding AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Elysium Health
  • Insilico Medicine
  • AgeX Therapeutics
  • Senolytic Therapeutics, Inc.
  • BioViva
  • Rejuvenate Bio
  • Calico Life Sciences
  • Altos Labs
Product Code: SMRC30398

According to Stratistics MRC, the Global Anti-aging Therapeutics Market is accounted for $991.12 million in 2025 and is expected to reach $3473.40 million by 2032 growing at a CAGR of 19.62% during the forecast period. Anti-aging therapeutics refers to medical treatments, interventions, and products designed to prevent, slow down, or reverse the biological processes associated with aging. This therapeutics aims to improve health span, enhance physical appearance, and maintain physiological functions by targeting cellular damage, oxidative stress, inflammation, and genetic factors that contribute to aging. They include pharmaceuticals, biologics, regenerative therapies, hormone replacements, and nutraceuticals. Anti-aging therapeutics may also address age-related diseases such as cardiovascular disorders, neurodegeneration, and osteoporosis.

Market Dynamics:

Driver:

Advancements in biotechnology & genomics

Precision medicine techniques improve safety and efficacy by customizing therapies to a patient's genetic composition. New approaches to repairing cellular damage and delaying ageing processes are provided by advances in gene editing, stem cell treatment, and regenerative medicine. The identification of biomarkers and aging-related genes through genomic research speeds up the creation of new drugs. These developments speed up the release of successful treatments onto the market by reducing trial-and-error in therapeutic design.

Restraint:

Lack of long-term clinical evidence

Customers continue to doubt the efficacy of products in the absence of substantiated long-term outcomes. Regulatory approvals are difficult to get because of inadequate data. Without strong clinical support, investors might be reluctant to fund ideas. Research, development, and the launch of novel treatments are slowed down as a result.

Opportunity:

Rising consumer awareness & preventive health attitudes

More and more people are looking for ways to stay healthy and look young. People who have preventive health attitudes are more likely to start therapies before they notice obvious symptoms of ageing. This mentality change encourages the early uptake of cutting-edge anti-aging treatments and solutions. Market expansion is also supported by growing awareness of the advantages of active substances and sophisticated formulations. Consequently, businesses are concentrating on marketing and research to serve this knowledgeable customer base.

Threat:

High treatment costs & limited reimbursement

A sizable section of the population still cannot afford many sophisticated therapies. Patients are further burdened financially by limited insurance coverage or reimbursement rules. This deters people from getting cosmetic or preventative care. As a result, high-income groups continue to have the greatest demand. These monetary obstacles impede the market's overall expansion and accessibility.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Anti-aging Therapeutics Market, disrupting supply chains, delaying clinical trials, and affecting manufacturing operations. Restrictions on elective and non-urgent treatments led to reduced patient visits, slowing product adoption. However, the crisis heightened consumer focus on health, wellness, and preventive care, indirectly supporting long-term market growth. The shift toward telemedicine and digital platforms enabled continued access to consultations and product information. Post-pandemic recovery is driven by renewed demand for advanced anti-aging solutions, increased R&D investment, and the resumption of aesthetic and therapeutic procedures.

The cellular aging segment is expected to be the largest during the forecast period

The cellular aging segment is expected to account for the largest market share during the forecast period by targeting the root causes of aging at the cellular level, such as DNA damage, telomere shortening, and oxidative stress. Innovations in senolytics, telomerase activators, and cell regeneration therapies are driving demand for advanced solutions. Growing research investments and clinical trials focusing on cellular repair mechanisms further accelerate market growth. Rising consumer awareness about preventive healthcare and longevity enhances adoption of these therapies. As a result, the cellular aging segment is becoming a key contributor to the overall expansion of the anti-aging therapeutics market.

The cognitive function segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive function segment is predicted to witness the highest growth rate due to addressing age-related decline in memory, focus, and mental clarity. Growing awareness about neurodegenerative diseases like Alzheimer's and dementia drives demand for preventive and therapeutic solutions. Advancements in no tropics, neuroprotective drugs, and regenerative therapies are expanding treatment options. Rising adoption of brain health supplements and lifestyle interventions further boosts market growth. Increasing research and clinical trials in cognitive enhancement strengthen the segment's contribution to the overall anti-aging market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share is driven by a high prevalence of lifestyle-related aging disorders, strong healthcare infrastructure, and growing demand for advanced regenerative medicine. Technologies such as stem cell therapy, gene editing, and peptide-based treatments are gaining prominence. Emerging trends include personalized anti-aging solutions and AI-driven diagnostics for early intervention. Key developments involve collaborations between biotech firms and research institutions for novel drug delivery systems.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR is fuelled by a rising aging population, increasing disposable incomes, and growing awareness of preventive healthcare. Technologies like nanomedicine, herbal-based therapeutics, and microbiome modulation are emerging. Trends include integration of traditional medicine with modern therapies and demand for non-invasive treatments.

Key players in the market

Some of the key players in Anti-aging Therapeutics Market include Unity Biotechnology, Novartis AG, Roche Holding AG, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., AstraZeneca plc, Johnson & Johnson, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Elysium Health, Insilico Medicine, AgeX Therapeutics, Senolytic Therapeutics, Inc., BioViva, Rejuvenate Bio, Calico Life Sciences and Altos Labs.

Key Developments:

In February 2025, Novartis acquired Anthos Therapeutics for US $925 million upfront, plus up to $2.15 billion in milestones. The acquisition secured abelacimab, a Factor XI inhibitor in Phase 3 trials for stroke prevention in atrial fibrillation, addressing a major cardiovascular risk predominantly affecting older adults.

In December 2024, Novartis entered a multi-year partnership with BioAge Labs to co discover novel therapeutic targets addressing age related diseases. Novartis provided up to US $20 M in upfront funding, while BioAge can earn up to $530 M in milestone payments.

In May 2024, Merck announced plans to acquire UK-based Eyebiotech (EyeBio), developer of Restoret/MK 3000 for age-related macular degeneration and diabetic macular edema. The agreement included $1.3 billion upfront and up to $1.7 billion in contingent milestone payments, totaling approximately $3 billion, strengthening Merck's portfolio in age-related eye disease therapies.

Type of Aging Covered:

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Other Type of Aging

Type of Molecules Covered:

  • Biologics
  • Small Molecules

Mechanism of Actions Covered:

  • Senolytics
  • Cell Regeneration
  • mTor Modulators
  • AMPK Activators
  • Telomerase Activators
  • Other Mechanism of Actions

Drug Classes Covered:

  • Hormonal Therapy
  • Antioxidants
  • Enzymes
  • Stem Cell Therapy
  • Other Drug Classes

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms

Applications Covered:

  • Skin & Hair Health
  • Skeletal & Muscular Health
  • Cognitive Function
  • Age-related Disorders
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Anti-aging Therapeutics Market, By Type of Aging

  • 5.1 Introduction
  • 5.2 Cellular Aging
  • 5.3 Immune Aging
  • 5.4 Metabolic Aging
  • 5.5 Other Types of Aging

6 Global Anti-aging Therapeutics Market, By Type of Molecule

  • 6.1 Introduction
  • 6.2 Biologics
  • 6.3 Small Molecules

7 Global Anti-aging Therapeutics Market, By Mechanism of Action

  • 7.1 Introduction
  • 7.2 Senolytics
  • 7.3 Cell Regeneration
  • 7.4 mTor Modulators
  • 7.5 AMPK Activators
  • 7.6 Telomerase Activators
  • 7.7 Other Mechanism of Actions

8 Global Anti-aging Therapeutics Market, By Drug Class

  • 8.1 Introduction
  • 8.2 Hormonal Therapy
  • 8.3 Antioxidants
  • 8.4 Enzymes
  • 8.5 Stem Cell Therapy
  • 8.6 Other Drug Classes

9 Global Anti-aging Therapeutics Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Hospital Pharmacies
  • 9.3 Retail Pharmacies
  • 9.4 Online Platforms

10 Global Anti-aging Therapeutics Market, By Application

  • 10.1 Introduction
  • 10.2 Skin & Hair Health
  • 10.3 Skeletal & Muscular Health
  • 10.4 Cognitive Function
  • 10.5 Age-related Disorders
  • 10.6 Other Applications

11 Global Anti-aging Therapeutics Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Unity Biotechnology
  • 13.2 Novartis AG
  • 13.3 Roche Holding AG
  • 13.4 Merck & Co., Inc.
  • 13.5 Pfizer Inc.
  • 13.6 Sanofi S.A.
  • 13.7 AstraZeneca plc
  • 13.8 Johnson & Johnson
  • 13.9 Abbott Laboratories
  • 13.10 Sun Pharmaceutical Industries Ltd.
  • 13.11 Elysium Health
  • 13.12 Insilico Medicine
  • 13.13 AgeX Therapeutics
  • 13.14 Senolytic Therapeutics, Inc.
  • 13.15 BioViva
  • 13.16 Rejuvenate Bio
  • 13.17 Calico Life Sciences
  • 13.18 Altos Labs

List of Tables

  • Table 1 Global Anti-aging Therapeutics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Anti-aging Therapeutics Market Outlook, By Type of Aging (2024-2032) ($MN)
  • Table 3 Global Anti-aging Therapeutics Market Outlook, By Cellular Aging (2024-2032) ($MN)
  • Table 4 Global Anti-aging Therapeutics Market Outlook, By Immune Aging (2024-2032) ($MN)
  • Table 5 Global Anti-aging Therapeutics Market Outlook, By Metabolic Aging (2024-2032) ($MN)
  • Table 6 Global Anti-aging Therapeutics Market Outlook, By Other Types of Aging (2024-2032) ($MN)
  • Table 7 Global Anti-aging Therapeutics Market Outlook, By Type of Molecule (2024-2032) ($MN)
  • Table 8 Global Anti-aging Therapeutics Market Outlook, By Biologics (2024-2032) ($MN)
  • Table 9 Global Anti-aging Therapeutics Market Outlook, By Small Molecules (2024-2032) ($MN)
  • Table 10 Global Anti-aging Therapeutics Market Outlook, By Mechanism of Action (2024-2032) ($MN)
  • Table 11 Global Anti-aging Therapeutics Market Outlook, By Senolytics (2024-2032) ($MN)
  • Table 12 Global Anti-aging Therapeutics Market Outlook, By Cell Regeneration (2024-2032) ($MN)
  • Table 13 Global Anti-aging Therapeutics Market Outlook, By mTor Modulators (2024-2032) ($MN)
  • Table 14 Global Anti-aging Therapeutics Market Outlook, By AMPK Activators (2024-2032) ($MN)
  • Table 15 Global Anti-aging Therapeutics Market Outlook, By Telomerase Activators (2024-2032) ($MN)
  • Table 16 Global Anti-aging Therapeutics Market Outlook, By Other Mechanism of Actions (2024-2032) ($MN)
  • Table 17 Global Anti-aging Therapeutics Market Outlook, By Drug Class (2024-2032) ($MN)
  • Table 18 Global Anti-aging Therapeutics Market Outlook, By Hormonal Therapy (2024-2032) ($MN)
  • Table 19 Global Anti-aging Therapeutics Market Outlook, By Antioxidants (2024-2032) ($MN)
  • Table 20 Global Anti-aging Therapeutics Market Outlook, By Enzymes (2024-2032) ($MN)
  • Table 21 Global Anti-aging Therapeutics Market Outlook, By Stem Cell Therapy (2024-2032) ($MN)
  • Table 22 Global Anti-aging Therapeutics Market Outlook, By Other Drug Classes (2024-2032) ($MN)
  • Table 23 Global Anti-aging Therapeutics Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Anti-aging Therapeutics Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 25 Global Anti-aging Therapeutics Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 26 Global Anti-aging Therapeutics Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 27 Global Anti-aging Therapeutics Market Outlook, By Application (2024-2032) ($MN)
  • Table 28 Global Anti-aging Therapeutics Market Outlook, By Skin & Hair Health (2024-2032) ($MN)
  • Table 29 Global Anti-aging Therapeutics Market Outlook, By Skeletal & Muscular Health (2024-2032) ($MN)
  • Table 30 Global Anti-aging Therapeutics Market Outlook, By Cognitive Function (2024-2032) ($MN)
  • Table 31 Global Anti-aging Therapeutics Market Outlook, By Age-related Disorders (2024-2032) ($MN)
  • Table 32 Global Anti-aging Therapeutics Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.